Secukinumab: The Real World Experience of PsA Patients
Ixekizumab vs. Adalimumab for PsA: How Do They Compare?
Psoriatic Arthritis: A Look Back at Moll & Wright’s Landmark 1973 Paper
Rheumatology Drugs at a Glance, Part 1: Psoriatic Arthritis
Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis
Canada Approves Erelzi for PsA; Plus FDA Moves to Increase Access to Naloxone
Results of SPIRIT: A Head-to-Head Trial of Ixekizumab vs. Adalimumab in Active PsA
Bimekizumab Promising for PsA
New Guideline for the Treatment of Psoriatic Arthritis
- 1
- 2
- 3
- …
- 9
- Next Page »